연구성과로 돌아가기

2024 연구자 정보 (38 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, Ji Sung
(Lee, JS)
Univ Ulsan, Asan Inst Life Sci, Coll Med, Clin Res Ctr,Asam Med Ctr, Seoul, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Lee, Sahmin
(Lee, S)
Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olympic ro 43 gil, Seoul 05505, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Lee, Sang Min
(Lee, SM)
Inje Univ Busan Paik Hosp, Busangingu, South Korea
Dankook Univ, Dept Internal Med, Coll Med, Cheonan, South Korea


[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
[JCR상위 32.0] Effect of biologic therapies on quality of life in severe asthma Findings from the PRISM study
SCIE 1.5 HEMATOLOGY
ALLERGY;IMMUNOLOGY
tbkim@amc.seoul.kr;
Lee, Yunji
(Lee, Y)
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Kyungpook Natl Univ, Sch Med, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea


[JCR상위 1.5] Nationwide Analysis on Incidences and Treatment Outcomes of T-Cell Subtype Lymphomas Based on Health Insurance Review & Assessment Service
[JCR상위 55.6] Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents?
[JCR상위 9.5] Clinical effect of prophylactic pegfilgrastim in patients with newly diagnosed acute lymphoblastic leukemia who receive intensive chemotherapy
[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
SCIE 1.5 HEMATOLOGY
HEALTH CARE SCIENCES & SERVICES;ONCOLOGY;REHABILITATION
baekdw83@gmail.com;
Lemieux, Christopher
(Lemieux, C)
Univ Laval, Ctr Integre Cancerol, CHU Quebec, Quebec City, PQ, Canada
CHU Quebec Univ Laval, Ctr Integre Cancerol, Quebec City, PQ, Canada


[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS
[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?
SCIE 1.5 HEMATOLOGY
Lepic, Kylie
(Lepic, K)
McMaster Univ, Juravinski Hosp, Dept Oncol, Hamilton, ON, Canada
McMaster Univ, Canc Ctr, Dept Oncol, Hamilton, ON, Canada


[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? SCIE 1.5 HEMATOLOGY
Mattsson, Jonas
(Mattsson, J)
Princess Margaret Hosp, Hans Messner Allogene Transplant Program, Div Med Oncol & Hematol, Toronto, ON, Canada

[JCR상위 1.5] Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse SCIE 1.5 HEMATOLOGY
Mehra, Varun
(Mehra, V)
Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England AAS-1390-2020
Mehra, Varun

[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS
[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?
SCIE 1.5 HEMATOLOGY
Oh, Sukjoong
(Oh, S)
Hanyang Univ, Med Ctr, Seoul, South Korea

[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 HEMATOLOGY
Park, Geuntae
(Park, G)
DGIST, Dept Elect Engn & Comp Sci, Daegu, South Korea
Kyungpook Natl Univ, Sch Elect & Elect Engn, Daegu 41566, South Korea


[JCR상위 1.5] Combustion-assisted low-temperature ZrO2/SnO2 films for high-performance flexible thin film transistors
[JCR상위 21.7] A Ripple-Based Real-Time Built-in-Resistance Compensation for Switching Battery Charger Achieving Fast Charging
SCIE 1.5 ENGINEERING, ELECTRICAL & ELECTRONIC;MATERIALS SCIENCE, MULTIDISCIPLINARY
ENGINEERING, ELECTRICAL & ELECTRONIC
hj.kwon@dgist.ac.kr;
kunhee@knu.ac.kr;
Park, Joon Seong
(Park, JS)
Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
Yonsei Univ, Coll Med, Dept Surg, Pancreatobiliary Clin, Seoul, South Korea
CZZ-0090-2022
Park, Jung Hoon
0000-0001-8048-9990
Park, Joon Seong
[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
[JCR상위 47.3] Practice guidelines for managing extrahepatic biliary tract cancers
SCIE
ESCI
1.5 HEMATOLOGY
GASTROENTEROLOGY & HEPATOLOGY;SURGERY
jspark330@yuhs.ac;
Park, Sangkyu
(Park, S)
Ulsan Univ Hosp, Ulsan, South Korea

[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) SCIE 1.5 HEMATOLOGY
Park, Seung-Woo
(Park, SW)
Samsung Med Ctr, Div Cardiol, Seoul, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Park, Sung-Ji
(Park, SJ)
Samsung Med Ctr, Div Cardiol, Seoul, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Park, Yong-Hyun
(Park, YH)
Pusan Natl Univ, Yangsan Hosp, Div Cardiol, Busan, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
페이지 이동: